"Canterbury Urology Research Trust is a charitable trust established in 1997"

Based in Christchurch, New Zealand, we conduct high quality research for international Urology clinical trials


Canterbury Urology Research Trust (CURT) is a charitable trust established by a group of urologists in 1997. CURT is a dedicated research centre based in Christchurch, New Zealand conducting national and international clinical Urology trials in conjunction with Urologists nationwide. We have access to a population of 560,000 locally in Canterbury, and 4.8 million around New Zealand.

The aim of the trust is to improve the care of urological patients primarily through research but also by assisting with professional development for nurses. Grants are available for attending seminars and conferences, and our annual Urology Interest Group day.

Read More


Although many of our trials are sponsored by pharmaceutical companies, Canterbury Urology Research Trust relies on your generosity to allow us to do our own research here in Christchurch.

A gift to CURT is a legacy that lasts beyond one’s lifetime, and helps to further the field of Urology. Your support will allow us to continue to do more life changing research.

Because we are a charitable trust, all donations are tax deductible up to the level of your income.

Read More

Our Trials

Currently recruiting:


Men diagnosed with metastatic prostate cancer

We have two trials which are about to start at the beginning of April. Please contact us if you would like further information.

Overactive Bladder

Starting April for men and women who have frequency and urge incontinence. Please contact us if you would like further information.



Past Trials

For more information on any of our past trials please contact us

  • Prostate Cancer – Palliative Radiotherapy
  • Prostate Cancer – rising PSA post treatment or newly diagnosed metastatic prostate cancer
  • Overactive Bladder
  • Prostate Cancer with metastases
  • Overactive Bladder with Incontinence
  • Hormone Resistant Prostate Cancer
  • Benign Prostatic Hyperplasia
  • Overactive Bladder – for patients with MS or spinal cord injury
  • Prostate Cancer – observational study
  • Prostate Cancer; hormone resistant, no metastases
  • Prostate Cancer – newly diagnosed
  • Bladder Cancer; monitoring
  • Bladder Cancer – evaluation
  • Prostate Cancer; hormone resistant
  • Peyronies
  • Prostate Cancer; stable
  • Soft Tissue Injury
  • DVT Prevention
  • Diverticulitis
  • Haematuria
  • Overactive Bladder (adult)
  • Diabetes
  • Testicular Cancer
  • Dyslipidaemia; high blood cholesterol
  • Atrial Fibrillation
  • Japanese Encephalitis
  • Osteoarthritis of the knee
  • Rheumatoid Arthritis; General
  • Crohns; medical treatment
  • Asthma; Moderate to severe
  • Rhinitis
  • Overactive Bladder (adult); open label extension
  • Crohns; medical treatment
  • Prostate Cancer; prevention
  • Irritable Bowel Syndrome; constipated predominant
  • Male Erectile Dysfunction
  • Benign Prostatic Hyperplasia; medical treatment
  • Overactive Bladder (paediatric) extension medical treatment
  • Asthma; Mild
  • Overactive Bladder (paediatric); medical treatment
  • Irritable Bowel Syndrome; diarrhoea predominant
  • A Kidney Stone Study; community study on the burden of stone disease; non pharmaceutical
  • Overactive Bladder (adult); medical treatment
  • Influenza; prevention
  • Female Stress Incontinence; urethral device
  • Benign Prostatic Hyperplasia; medical treatment
  • Benign Prostatic Hyperplasia; genotyping

Read More